Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ: RADX - Get Free Report) have been given an average recommendation of "Buy" by the five analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, two have given a buy rating and two have given a strong buy